Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 7.92503619 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 7.92503619 |
3 | protein maturation by protein folding (GO:0022417) | 5.61656234 |
4 | peptide hormone processing (GO:0016486) | 5.50516623 |
5 | endocrine pancreas development (GO:0031018) | 5.22939690 |
6 | insulin secretion (GO:0030073) | 4.97354330 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.92818629 |
8 | detection of calcium ion (GO:0005513) | 4.68460583 |
9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.64691172 |
10 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.61411034 |
11 | COPII vesicle coating (GO:0048208) | 4.48063360 |
12 | glycerophospholipid catabolic process (GO:0046475) | 4.43763682 |
13 | ER overload response (GO:0006983) | 4.34306777 |
14 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.32797719 |
15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.26259028 |
16 | regulation of insulin secretion (GO:0050796) | 4.16944336 |
17 | positive regulation of insulin secretion (GO:0032024) | 4.15191168 |
18 | succinate metabolic process (GO:0006105) | 4.14239419 |
19 | cellular ketone body metabolic process (GO:0046950) | 4.10831579 |
20 | glandular epithelial cell differentiation (GO:0002067) | 4.08958075 |
21 | vesicle coating (GO:0006901) | 4.03942196 |
22 | signal peptide processing (GO:0006465) | 4.03506399 |
23 | epithelial cell fate commitment (GO:0072148) | 4.03498196 |
24 | type B pancreatic cell development (GO:0003323) | 3.97411888 |
25 | protein retention in ER lumen (GO:0006621) | 3.90418127 |
26 | negative regulation of catecholamine secretion (GO:0033604) | 3.86291604 |
27 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.82159048 |
28 | regulation of peptide hormone secretion (GO:0090276) | 3.80545204 |
29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.75826229 |
30 | regulation of peptide secretion (GO:0002791) | 3.75077691 |
31 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.73707346 |
32 | peptide hormone secretion (GO:0030072) | 3.71938972 |
33 | cerebellar Purkinje cell layer development (GO:0021680) | 3.61325717 |
34 | ketone body metabolic process (GO:1902224) | 3.61145097 |
35 | peptide secretion (GO:0002790) | 3.61035595 |
36 | positive regulation of nuclease activity (GO:0032075) | 3.60178097 |
37 | regulation of glucocorticoid secretion (GO:2000849) | 3.59709440 |
38 | negative regulation of norepinephrine secretion (GO:0010700) | 3.57689078 |
39 | neuron cell-cell adhesion (GO:0007158) | 3.56267118 |
40 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.55324031 |
41 | glandular epithelial cell development (GO:0002068) | 3.53651380 |
42 | sequestering of metal ion (GO:0051238) | 3.49166788 |
43 | exocrine pancreas development (GO:0031017) | 3.47685298 |
44 | inositol phosphate catabolic process (GO:0071545) | 3.47121765 |
45 | toxin metabolic process (GO:0009404) | 3.47086696 |
46 | positive regulation of peptide hormone secretion (GO:0090277) | 3.43844458 |
47 | protein-cofactor linkage (GO:0018065) | 3.42558337 |
48 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.41589521 |
49 | cellular response to glucagon stimulus (GO:0071377) | 3.40272281 |
50 | nitric oxide mediated signal transduction (GO:0007263) | 3.38069081 |
51 | positive regulation of peptide secretion (GO:0002793) | 3.37084949 |
52 | neurotransmitter biosynthetic process (GO:0042136) | 3.35829745 |
53 | synaptic vesicle exocytosis (GO:0016079) | 3.34362688 |
54 | regulation of hormone secretion (GO:0046883) | 3.33896564 |
55 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.26534020 |
56 | regulation of nuclease activity (GO:0032069) | 3.23871970 |
57 | synaptic vesicle maturation (GO:0016188) | 3.21264869 |
58 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.20320914 |
59 | proline transport (GO:0015824) | 3.18559232 |
60 | regulation of synaptic vesicle transport (GO:1902803) | 3.18336063 |
61 | activation of protein kinase A activity (GO:0034199) | 3.17847862 |
62 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.16704269 |
63 | inositol phosphate dephosphorylation (GO:0046855) | 3.16704269 |
64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15266892 |
65 | protein targeting to Golgi (GO:0000042) | 3.15166492 |
66 | nonmotile primary cilium assembly (GO:0035058) | 3.15124264 |
67 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.11855588 |
68 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.10352634 |
69 | protein localization to Golgi apparatus (GO:0034067) | 3.09004759 |
70 | cAMP catabolic process (GO:0006198) | 3.07316155 |
71 | inner ear receptor cell development (GO:0060119) | 3.07066608 |
72 | response to pheromone (GO:0019236) | 3.06209058 |
73 | cellular response to unfolded protein (GO:0034620) | 3.05820804 |
74 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.05716596 |
75 | hormone secretion (GO:0046879) | 3.05610112 |
76 | dendritic spine morphogenesis (GO:0060997) | 3.03756684 |
77 | positive regulation of exocytosis (GO:0045921) | 3.02912739 |
78 | regulation of peptide transport (GO:0090087) | 3.02488651 |
79 | positive regulation of amino acid transport (GO:0051957) | 2.99807555 |
80 | cellular response to topologically incorrect protein (GO:0035967) | 2.99262848 |
81 | nucleobase catabolic process (GO:0046113) | 2.99168424 |
82 | dicarboxylic acid catabolic process (GO:0043649) | 2.99094157 |
83 | ER-nucleus signaling pathway (GO:0006984) | 2.98144155 |
84 | glutamate secretion (GO:0014047) | 2.97159874 |
85 | chemosensory behavior (GO:0007635) | 2.94286219 |
86 | dopamine biosynthetic process (GO:0042416) | 2.93294608 |
87 | neuromuscular process controlling posture (GO:0050884) | 2.93161886 |
88 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.92918458 |
89 | axonal fasciculation (GO:0007413) | 2.92502517 |
90 | alanine transport (GO:0032328) | 2.90681321 |
91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90491931 |
92 | cyclic nucleotide catabolic process (GO:0009214) | 2.89786302 |
93 | macroautophagy (GO:0016236) | 2.88998305 |
94 | negative regulation of insulin secretion (GO:0046676) | 2.88703757 |
95 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.88609565 |
96 | regulation of hexokinase activity (GO:1903299) | 2.88502917 |
97 | regulation of glucokinase activity (GO:0033131) | 2.88502917 |
98 | hormone transport (GO:0009914) | 2.87585080 |
99 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.87546268 |
100 | signal release (GO:0023061) | 2.86964268 |
101 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.86296544 |
102 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.85255181 |
103 | protein localization to cilium (GO:0061512) | 2.84744335 |
104 | brain morphogenesis (GO:0048854) | 2.83441176 |
105 | gamma-aminobutyric acid transport (GO:0015812) | 2.83283389 |
106 | regulation of neurotransmitter uptake (GO:0051580) | 2.83031814 |
107 | regulation of exocytosis (GO:0017157) | 2.81721064 |
108 | negative regulation of amine transport (GO:0051953) | 2.81562829 |
109 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.80165920 |
110 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.79844677 |
111 | regulation of norepinephrine secretion (GO:0014061) | 2.79111144 |
112 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.78751852 |
113 | response to corticosterone (GO:0051412) | 2.78400048 |
114 | peptidyl-asparagine modification (GO:0018196) | 2.78323417 |
115 | establishment of protein localization to Golgi (GO:0072600) | 2.76937267 |
116 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.76746680 |
117 | catechol-containing compound biosynthetic process (GO:0009713) | 2.76432437 |
118 | catecholamine biosynthetic process (GO:0042423) | 2.76432437 |
119 | peptide transport (GO:0015833) | 2.76235584 |
120 | presynaptic membrane assembly (GO:0097105) | 2.75404861 |
121 | mating behavior (GO:0007617) | 2.75274385 |
122 | sulfation (GO:0051923) | 2.74828435 |
123 | positive regulation of hormone secretion (GO:0046887) | 2.74515054 |
124 | positive regulation of mitochondrial fission (GO:0090141) | 2.74031627 |
125 | neurotransmitter secretion (GO:0007269) | 2.72094072 |
126 | response to dietary excess (GO:0002021) | 2.71598215 |
127 | eating behavior (GO:0042755) | 2.71217781 |
128 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.70878850 |
129 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.70002006 |
130 | regulation of vesicle fusion (GO:0031338) | 2.68495717 |
131 | negative regulation of peptide hormone secretion (GO:0090278) | 2.67076892 |
132 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.66854918 |
133 | glycosphingolipid biosynthetic process (GO:0006688) | 2.66437013 |
134 | regulation of beta-amyloid formation (GO:1902003) | 2.65916613 |
135 | glutamate receptor signaling pathway (GO:0007215) | 2.65209010 |
136 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.64652172 |
137 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.64011181 |
138 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.63332438 |
139 | astrocyte differentiation (GO:0048708) | 2.63306602 |
140 | regulation of dopamine metabolic process (GO:0042053) | 2.63210864 |
141 | regulation of catecholamine metabolic process (GO:0042069) | 2.63210864 |
142 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.63007364 |
143 | innervation (GO:0060384) | 2.62930620 |
144 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.62017647 |
145 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.61671506 |
146 | presynaptic membrane organization (GO:0097090) | 2.61155459 |
147 | positive regulation of gluconeogenesis (GO:0045722) | 2.59277165 |
148 | regulation of Rac protein signal transduction (GO:0035020) | 2.58719322 |
149 | calcium ion import (GO:0070509) | 2.56179035 |
150 | locomotory exploration behavior (GO:0035641) | 2.54875066 |
151 | neurotransmitter metabolic process (GO:0042133) | 2.54268549 |
152 | auditory receptor cell differentiation (GO:0042491) | 2.53520138 |
153 | polyol catabolic process (GO:0046174) | 2.53038315 |
154 | neurotransmitter transport (GO:0006836) | 2.52441587 |
155 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.51347504 |
156 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.51149104 |
157 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.51149104 |
158 | artery smooth muscle contraction (GO:0014824) | 2.50255191 |
159 | catecholamine transport (GO:0051937) | 2.48926238 |
160 | synapse assembly (GO:0007416) | 2.48260834 |
161 | dopamine transport (GO:0015872) | 2.47094932 |
162 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.46708116 |
163 | regulation of neurotransmitter levels (GO:0001505) | 2.46600348 |
164 | regulation of action potential (GO:0098900) | 2.45827703 |
165 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.45169284 |
166 | melanosome transport (GO:0032402) | 2.43058065 |
167 | C-terminal protein lipidation (GO:0006501) | 2.41813545 |
168 | positive regulation of calcium ion import (GO:0090280) | 2.41303117 |
169 | calcium ion-dependent exocytosis (GO:0017156) | 2.38732020 |
170 | establishment of melanosome localization (GO:0032401) | 2.38373400 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.38004760 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84136732 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29020828 |
4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90391433 |
5 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.42186927 |
6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41464868 |
7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40077131 |
8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.34615184 |
9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34014230 |
10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24567224 |
11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.20897302 |
12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17838933 |
13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.15578724 |
14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14116400 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03948275 |
16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02353175 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96080201 |
18 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.89642648 |
19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88305393 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86436310 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85528423 |
22 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.85073870 |
23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.83726803 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82338719 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80489980 |
26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80152262 |
27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.73948544 |
28 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70379259 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69359665 |
30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69241105 |
31 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69051914 |
32 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68553087 |
33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66031763 |
34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.65428445 |
35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65411594 |
36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61711115 |
37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.57564933 |
38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56516075 |
39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53046624 |
40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52322499 |
41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50327520 |
42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48474961 |
43 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47937554 |
44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46260324 |
45 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.45354773 |
46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45144037 |
47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45144037 |
48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43686302 |
49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42531565 |
50 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42103317 |
51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41011663 |
52 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40604971 |
53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40388089 |
54 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39904836 |
55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39831469 |
56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36898628 |
57 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36291727 |
58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35696946 |
59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33348468 |
60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30066686 |
61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29597341 |
62 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29272040 |
63 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23995513 |
64 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.23512063 |
65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23267539 |
66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22084388 |
67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21821504 |
68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20591815 |
69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19277921 |
70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17621126 |
71 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17390632 |
72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16950114 |
73 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15763557 |
74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15221733 |
75 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15042584 |
76 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14837137 |
77 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14505128 |
78 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14084954 |
79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13969369 |
80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13444567 |
81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13035921 |
82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10569547 |
83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10361130 |
84 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.09780874 |
85 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09039478 |
86 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.08426291 |
87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06334605 |
88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05647350 |
89 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05567463 |
90 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04704711 |
91 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04163693 |
92 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04032992 |
93 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03376774 |
94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03218810 |
95 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02972492 |
96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02542321 |
97 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02449981 |
98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01135084 |
99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01135084 |
100 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00804654 |
101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00750882 |
102 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00206540 |
103 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99941723 |
104 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99379060 |
105 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98791021 |
106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98499094 |
107 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97965453 |
108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97074253 |
109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96849101 |
110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96444579 |
111 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94547061 |
112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93753638 |
113 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92965265 |
114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91845028 |
115 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91721888 |
116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91364802 |
117 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90623023 |
118 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88568405 |
119 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88339455 |
120 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86998508 |
121 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86401173 |
122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84782826 |
123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82471146 |
124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82306795 |
125 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81949330 |
126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81894083 |
127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81894083 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002909_abnormal_adrenal_gland | 4.02220921 |
2 | MP0009780_abnormal_chondrocyte_physiolo | 3.82972510 |
3 | MP0002877_abnormal_melanocyte_morpholog | 3.75216999 |
4 | MP0003283_abnormal_digestive_organ | 3.68590621 |
5 | MP0000013_abnormal_adipose_tissue | 3.48575215 |
6 | MP0003122_maternal_imprinting | 3.46566151 |
7 | MP0004043_abnormal_pH_regulation | 3.36997763 |
8 | MP0002693_abnormal_pancreas_physiology | 3.35963519 |
9 | MP0010386_abnormal_urinary_bladder | 3.15263120 |
10 | MP0001944_abnormal_pancreas_morphology | 2.85111092 |
11 | MP0003183_abnormal_peptide_metabolism | 2.82857551 |
12 | MP0005645_abnormal_hypothalamus_physiol | 2.77157787 |
13 | MP0005379_endocrine/exocrine_gland_phen | 2.75745120 |
14 | MP0002837_dystrophic_cardiac_calcinosis | 2.64159586 |
15 | MP0005646_abnormal_pituitary_gland | 2.63799803 |
16 | MP0003195_calcinosis | 2.39507879 |
17 | MP0006072_abnormal_retinal_apoptosis | 2.35344774 |
18 | MP0000678_abnormal_parathyroid_gland | 2.33567088 |
19 | MP0008877_abnormal_DNA_methylation | 2.22251016 |
20 | MP0002876_abnormal_thyroid_physiology | 2.19085159 |
21 | MP0004270_analgesia | 2.17127319 |
22 | MP0002638_abnormal_pupillary_reflex | 2.00048087 |
23 | MP0003635_abnormal_synaptic_transmissio | 1.99532918 |
24 | MP0002078_abnormal_glucose_homeostasis | 1.95004162 |
25 | MP0004859_abnormal_synaptic_plasticity | 1.91659216 |
26 | MP0006276_abnormal_autonomic_nervous | 1.83041175 |
27 | MP0003787_abnormal_imprinting | 1.79259937 |
28 | MP0001986_abnormal_taste_sensitivity | 1.78679363 |
29 | MP0000631_abnormal_neuroendocrine_gland | 1.77692202 |
30 | MP0005220_abnormal_exocrine_pancreas | 1.68266440 |
31 | MP0001502_abnormal_circadian_rhythm | 1.64546181 |
32 | MP0000003_abnormal_adipose_tissue | 1.61686657 |
33 | MP0002572_abnormal_emotion/affect_behav | 1.60833983 |
34 | MP0002734_abnormal_mechanical_nocicepti | 1.60217415 |
35 | MP0002733_abnormal_thermal_nociception | 1.58534319 |
36 | MP0000569_abnormal_digit_pigmentation | 1.57412089 |
37 | MP0002063_abnormal_learning/memory/cond | 1.52851575 |
38 | MP0002272_abnormal_nervous_system | 1.50413533 |
39 | MP0001501_abnormal_sleep_pattern | 1.49881471 |
40 | MP0002139_abnormal_hepatobiliary_system | 1.47601438 |
41 | MP0009745_abnormal_behavioral_response | 1.45412905 |
42 | MP0002064_seizures | 1.45404450 |
43 | MP0002822_catalepsy | 1.39635779 |
44 | MP0004885_abnormal_endolymph | 1.39419108 |
45 | MP0003953_abnormal_hormone_level | 1.36232204 |
46 | MP0008961_abnormal_basal_metabolism | 1.36058926 |
47 | MP0005535_abnormal_body_temperature | 1.35310631 |
48 | MP0003880_abnormal_central_pattern | 1.33313067 |
49 | MP0001970_abnormal_pain_threshold | 1.33163063 |
50 | MP0003172_abnormal_lysosome_physiology | 1.31278327 |
51 | MP0010329_abnormal_lipoprotein_level | 1.28942838 |
52 | MP0001765_abnormal_ion_homeostasis | 1.22854119 |
53 | MP0002557_abnormal_social/conspecific_i | 1.22478826 |
54 | MP0002234_abnormal_pharynx_morphology | 1.21165306 |
55 | MP0003121_genomic_imprinting | 1.17430633 |
56 | MP0009046_muscle_twitch | 1.14928428 |
57 | MP0003879_abnormal_hair_cell | 1.13007795 |
58 | MP0005332_abnormal_amino_acid | 1.12895824 |
59 | MP0003959_abnormal_lean_body | 1.11303942 |
60 | MP0002163_abnormal_gland_morphology | 1.10283260 |
61 | MP0002735_abnormal_chemical_nociception | 1.10146683 |
62 | MP0003123_paternal_imprinting | 1.09833376 |
63 | MP0000681_abnormal_thyroid_gland | 1.08834743 |
64 | MP0004264_abnormal_extraembryonic_tissu | 1.08522353 |
65 | MP0005386_behavior/neurological_phenoty | 1.06530415 |
66 | MP0004924_abnormal_behavior | 1.06530415 |
67 | MP0001756_abnormal_urination | 1.05991251 |
68 | MP0004133_heterotaxia | 1.05813086 |
69 | MP0001188_hyperpigmentation | 1.05804967 |
70 | MP0010234_abnormal_vibrissa_follicle | 1.05636598 |
71 | MP0005253_abnormal_eye_physiology | 1.05338840 |
72 | MP0002896_abnormal_bone_mineralization | 1.04617758 |
73 | MP0003631_nervous_system_phenotype | 1.04587628 |
74 | MP0001440_abnormal_grooming_behavior | 1.04494553 |
75 | MP0005187_abnormal_penis_morphology | 1.03093753 |
76 | MP0002067_abnormal_sensory_capabilities | 1.03075197 |
77 | MP0004019_abnormal_vitamin_homeostasis | 1.02972242 |
78 | MP0001529_abnormal_vocalization | 1.01257728 |
79 | MP0001984_abnormal_olfaction | 1.00918052 |
80 | MP0001968_abnormal_touch/_nociception | 1.00658754 |
81 | MP0002928_abnormal_bile_duct | 0.99971434 |
82 | MP0002102_abnormal_ear_morphology | 0.99951841 |
83 | MP0000462_abnormal_digestive_system | 0.99830832 |
84 | MP0000639_abnormal_adrenal_gland | 0.99525139 |
85 | MP0005448_abnormal_energy_balance | 0.98568536 |
86 | MP0002184_abnormal_innervation | 0.97276006 |
87 | MP0001299_abnormal_eye_distance/ | 0.95327615 |
88 | MP0003632_abnormal_nervous_system | 0.93610427 |
89 | MP0003868_abnormal_feces_composition | 0.93312465 |
90 | MP0002090_abnormal_vision | 0.92805675 |
91 | MP0000516_abnormal_urinary_system | 0.92248935 |
92 | MP0005367_renal/urinary_system_phenotyp | 0.92248935 |
93 | MP0001486_abnormal_startle_reflex | 0.90041243 |
94 | MP0004215_abnormal_myocardial_fiber | 0.89777109 |
95 | MP0005423_abnormal_somatic_nervous | 0.89741251 |
96 | MP0002736_abnormal_nociception_after | 0.89066489 |
97 | MP0000955_abnormal_spinal_cord | 0.88906113 |
98 | MP0002069_abnormal_eating/drinking_beha | 0.88417398 |
99 | MP0005551_abnormal_eye_electrophysiolog | 0.88190161 |
100 | MP0004145_abnormal_muscle_electrophysio | 0.85123966 |
101 | MP0001270_distended_abdomen | 0.85038228 |
102 | MP0000427_abnormal_hair_cycle | 0.84319316 |
103 | MP0005058_abnormal_lysosome_morphology | 0.83934072 |
104 | MP0002229_neurodegeneration | 0.83886330 |
105 | MP0003329_amyloid_beta_deposits | 0.83644674 |
106 | MP0004811_abnormal_neuron_physiology | 0.82423412 |
107 | MP0003011_delayed_dark_adaptation | 0.82132903 |
108 | MP0000613_abnormal_salivary_gland | 0.79309635 |
109 | MP0005310_abnormal_salivary_gland | 0.78712656 |
110 | MP0008569_lethality_at_weaning | 0.77494623 |
111 | MP0000230_abnormal_systemic_arterial | 0.76520319 |
112 | MP0004085_abnormal_heartbeat | 0.76432153 |
113 | MP0002066_abnormal_motor_capabilities/c | 0.76274199 |
114 | MP0005636_abnormal_mineral_homeostasis | 0.75086507 |
115 | MP0001664_abnormal_digestion | 0.74739044 |
116 | MP0008872_abnormal_physiological_respon | 0.74056361 |
117 | MP0002882_abnormal_neuron_morphology | 0.72785426 |
118 | MP0002254_reproductive_system_inflammat | 0.71673209 |
119 | MP0001905_abnormal_dopamine_level | 0.68967844 |
120 | MP0000538_abnormal_urinary_bladder | 0.68773648 |
121 | MP0004142_abnormal_muscle_tone | 0.68299215 |
122 | MP0003634_abnormal_glial_cell | 0.66978150 |
123 | MP0003633_abnormal_nervous_system | 0.66159557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.01158298 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.46999391 |
3 | Hypoglycemic seizures (HP:0002173) | 5.84323821 |
4 | Symptomatic seizures (HP:0011145) | 5.46473086 |
5 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.61455563 |
6 | Hypoglycemic coma (HP:0001325) | 4.45501257 |
7 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.18617686 |
8 | Agitation (HP:0000713) | 4.00496497 |
9 | Hyperglycemia (HP:0003074) | 3.90936453 |
10 | Intestinal atresia (HP:0011100) | 3.88099859 |
11 | Decreased circulating renin level (HP:0003351) | 3.79452785 |
12 | Visual hallucinations (HP:0002367) | 3.76904219 |
13 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.73286177 |
14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.73286177 |
15 | Large for gestational age (HP:0001520) | 3.56489233 |
16 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.50892015 |
17 | Ketoacidosis (HP:0001993) | 3.50093587 |
18 | Pheochromocytoma (HP:0002666) | 3.48641885 |
19 | Menstrual irregularities (HP:0000858) | 3.42941241 |
20 | Hemiparesis (HP:0001269) | 3.26321454 |
21 | Failure to thrive in infancy (HP:0001531) | 3.24076049 |
22 | Hypothermia (HP:0002045) | 3.22296383 |
23 | Abnormal pancreas size (HP:0012094) | 3.20119972 |
24 | Late onset (HP:0003584) | 3.15494639 |
25 | Congenital malformation of the right heart (HP:0011723) | 3.11822686 |
26 | Double outlet right ventricle (HP:0001719) | 3.11822686 |
27 | Neuroendocrine neoplasm (HP:0100634) | 3.07842211 |
28 | Hyperparathyroidism (HP:0000843) | 2.96516035 |
29 | EEG with generalized epileptiform discharges (HP:0011198) | 2.95862721 |
30 | Papilledema (HP:0001085) | 2.92632480 |
31 | Hypercortisolism (HP:0001578) | 2.90851274 |
32 | Polyphagia (HP:0002591) | 2.90390199 |
33 | Hypokalemia (HP:0002900) | 2.88615151 |
34 | Epileptiform EEG discharges (HP:0011182) | 2.88551829 |
35 | Mucopolysacchariduria (HP:0008155) | 2.87213732 |
36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.87213732 |
37 | Hypsarrhythmia (HP:0002521) | 2.86182388 |
38 | Dysostosis multiplex (HP:0000943) | 2.81453009 |
39 | Atonic seizures (HP:0010819) | 2.77833337 |
40 | Osteomalacia (HP:0002749) | 2.75198141 |
41 | Abnormality of vitamin B metabolism (HP:0004340) | 2.68693655 |
42 | Hyperventilation (HP:0002883) | 2.66119254 |
43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65436964 |
44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65436964 |
45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65436964 |
46 | Proximal tubulopathy (HP:0000114) | 2.54339750 |
47 | Abnormality of renin-angiotensin system (HP:0000847) | 2.52148472 |
48 | Hypokinesia (HP:0002375) | 2.51594082 |
49 | Oligomenorrhea (HP:0000876) | 2.50878907 |
50 | Growth hormone excess (HP:0000845) | 2.49683789 |
51 | Focal motor seizures (HP:0011153) | 2.47116234 |
52 | Generalized aminoaciduria (HP:0002909) | 2.45503826 |
53 | Absence seizures (HP:0002121) | 2.45492618 |
54 | Retinal atrophy (HP:0001105) | 2.39703630 |
55 | Dysautonomia (HP:0002459) | 2.33493388 |
56 | Abnormality of vitamin metabolism (HP:0100508) | 2.31562605 |
57 | Restlessness (HP:0000711) | 2.29938986 |
58 | Abnormality of potassium homeostasis (HP:0011042) | 2.29034364 |
59 | Diminished movement (HP:0002374) | 2.28707913 |
60 | Anxiety (HP:0000739) | 2.28570255 |
61 | Nephronophthisis (HP:0000090) | 2.27135354 |
62 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27048786 |
63 | Macroorchidism (HP:0000053) | 2.26242609 |
64 | Gaze-evoked nystagmus (HP:0000640) | 2.26077599 |
65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25233741 |
66 | Progressive cerebellar ataxia (HP:0002073) | 2.24929876 |
67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22629710 |
68 | Enlarged penis (HP:0000040) | 2.20547436 |
69 | Spastic tetraplegia (HP:0002510) | 2.19992896 |
70 | Increased CSF protein (HP:0002922) | 2.18407309 |
71 | Pancreatic fibrosis (HP:0100732) | 2.17722917 |
72 | Limb dystonia (HP:0002451) | 2.17661510 |
73 | Testicular neoplasm (HP:0010788) | 2.16992756 |
74 | Genital tract atresia (HP:0001827) | 2.16942863 |
75 | Limb hypertonia (HP:0002509) | 2.15060794 |
76 | Dialeptic seizures (HP:0011146) | 2.13760798 |
77 | Depression (HP:0000716) | 2.13386701 |
78 | Progressive macrocephaly (HP:0004481) | 2.12773570 |
79 | Adrenal overactivity (HP:0002717) | 2.12455934 |
80 | Cortical visual impairment (HP:0100704) | 2.12281807 |
81 | Insulin resistance (HP:0000855) | 2.12224758 |
82 | Methylmalonic acidemia (HP:0002912) | 2.10926267 |
83 | Poor suck (HP:0002033) | 2.10663442 |
84 | Glycosuria (HP:0003076) | 2.09273269 |
85 | Abnormality of urine glucose concentration (HP:0011016) | 2.09273269 |
86 | Abnormal eating behavior (HP:0100738) | 2.08081227 |
87 | Generalized tonic-clonic seizures (HP:0002069) | 2.07534821 |
88 | Hyperphosphatemia (HP:0002905) | 2.05172873 |
89 | Prominent metopic ridge (HP:0005487) | 2.03403396 |
90 | Vaginal atresia (HP:0000148) | 2.03313256 |
91 | Unilateral renal agenesis (HP:0000122) | 2.03297248 |
92 | Epileptic encephalopathy (HP:0200134) | 2.02269661 |
93 | Pancreatic cysts (HP:0001737) | 2.01727174 |
94 | Molar tooth sign on MRI (HP:0002419) | 2.01528886 |
95 | Abnormality of midbrain morphology (HP:0002418) | 2.01528886 |
96 | Syncope (HP:0001279) | 2.01435867 |
97 | Increased circulating renin level (HP:0000848) | 2.00527330 |
98 | Hyperkalemia (HP:0002153) | 2.00523450 |
99 | Resting tremor (HP:0002322) | 1.99684629 |
100 | Truncal ataxia (HP:0002078) | 1.99027305 |
101 | Type II lissencephaly (HP:0007260) | 1.98871622 |
102 | Hypoalbuminemia (HP:0003073) | 1.98587944 |
103 | Abnormal albumin level (HP:0012116) | 1.98587944 |
104 | Postural tremor (HP:0002174) | 1.97655711 |
105 | Focal seizures (HP:0007359) | 1.97528954 |
106 | Poor coordination (HP:0002370) | 1.96360697 |
107 | Generalized myoclonic seizures (HP:0002123) | 1.95788961 |
108 | Prominent supraorbital ridges (HP:0000336) | 1.95066756 |
109 | Vascular calcification (HP:0004934) | 1.92377081 |
110 | Acute necrotizing encephalopathy (HP:0006965) | 1.92021148 |
111 | Gait imbalance (HP:0002141) | 1.90949218 |
112 | Abnormality of the fovea (HP:0000493) | 1.88888068 |
113 | Hypoplasia of the fovea (HP:0007750) | 1.88020536 |
114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88020536 |
115 | Hyperactive renin-angiotensin system (HP:0000841) | 1.87942801 |
116 | Renal Fanconi syndrome (HP:0001994) | 1.86148852 |
117 | Medial flaring of the eyebrow (HP:0010747) | 1.84738209 |
118 | Muscular hypotonia of the trunk (HP:0008936) | 1.84726482 |
119 | Focal dystonia (HP:0004373) | 1.84079152 |
120 | Progressive neurologic deterioration (HP:0002344) | 1.83713575 |
121 | Lissencephaly (HP:0001339) | 1.83183154 |
122 | Hypotension (HP:0002615) | 1.83167363 |
123 | True hermaphroditism (HP:0010459) | 1.82684390 |
124 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.80951493 |
125 | Congenital primary aphakia (HP:0007707) | 1.80516796 |
126 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80258098 |
127 | Abnormal drinking behavior (HP:0030082) | 1.79810191 |
128 | Polydipsia (HP:0001959) | 1.79810191 |
129 | Abnormality of renal resorption (HP:0011038) | 1.78834209 |
130 | Exocrine pancreatic insufficiency (HP:0001738) | 1.78713313 |
131 | Tongue fasciculations (HP:0001308) | 1.78671765 |
132 | Hypophosphatemia (HP:0002148) | 1.78473021 |
133 | Specific learning disability (HP:0001328) | 1.78329492 |
134 | Amblyopia (HP:0000646) | 1.78247052 |
135 | Psychosis (HP:0000709) | 1.77775858 |
136 | Abnormality of the renal medulla (HP:0100957) | 1.77500876 |
137 | Left ventricular hypertrophy (HP:0001712) | 1.76212895 |
138 | Absent speech (HP:0001344) | 1.75936507 |
139 | Intention tremor (HP:0002080) | 1.75500084 |
140 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74901766 |
141 | Hyperthyroidism (HP:0000836) | 1.73887187 |
142 | Neoplasm of the heart (HP:0100544) | 1.72211615 |
143 | Gout (HP:0001997) | 1.70108822 |
144 | Congenital glaucoma (HP:0001087) | 1.68762825 |
145 | Ketosis (HP:0001946) | 1.68705909 |
146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68390241 |
147 | Abnormality of the metopic suture (HP:0005556) | 1.68265992 |
148 | Chronic bronchitis (HP:0004469) | 1.67271858 |
149 | Abnormal hair whorl (HP:0010721) | 1.67066794 |
150 | Type II diabetes mellitus (HP:0005978) | 1.66875019 |
151 | Hypocalcemia (HP:0002901) | 1.65977235 |
152 | Febrile seizures (HP:0002373) | 1.63516350 |
153 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62756233 |
154 | Nephrogenic diabetes insipidus (HP:0009806) | 1.62537416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 6.03478755 |
2 | PASK | 4.46701463 |
3 | NTRK3 | 3.88315665 |
4 | PRKD3 | 3.22702904 |
5 | TAOK3 | 3.07419264 |
6 | MAPK15 | 2.99456175 |
7 | MAP3K2 | 2.96867355 |
8 | PHKG1 | 2.95737390 |
9 | PHKG2 | 2.95737390 |
10 | HIPK2 | 2.66746991 |
11 | STK38L | 2.38317359 |
12 | FRK | 2.28849625 |
13 | UHMK1 | 2.28558470 |
14 | NTRK1 | 2.22639855 |
15 | MAP4K2 | 2.22465328 |
16 | FGFR2 | 2.02400524 |
17 | CSNK1G3 | 1.99752061 |
18 | CSNK1G1 | 1.99624840 |
19 | CAMKK2 | 1.96126879 |
20 | PINK1 | 1.91915433 |
21 | AKT3 | 1.81553355 |
22 | GRK1 | 1.80725732 |
23 | MAP3K4 | 1.79514107 |
24 | MAP3K1 | 1.79314677 |
25 | WNK4 | 1.76154196 |
26 | WNK3 | 1.73105740 |
27 | SCYL2 | 1.71573024 |
28 | CDC42BPA | 1.56776414 |
29 | MAP2K6 | 1.51343833 |
30 | MAP2K7 | 1.42462228 |
31 | CSNK1A1L | 1.38563521 |
32 | PAK3 | 1.37058028 |
33 | MARK1 | 1.32384144 |
34 | GRK5 | 1.29642373 |
35 | PRKCH | 1.29055756 |
36 | MAP3K9 | 1.28339006 |
37 | MST4 | 1.25321143 |
38 | IRAK3 | 1.20139278 |
39 | FLT3 | 1.19673496 |
40 | STK38 | 1.16730471 |
41 | PNCK | 1.15900378 |
42 | GRK7 | 1.15061994 |
43 | LMTK2 | 1.11256504 |
44 | IRAK1 | 1.10538741 |
45 | MAP3K12 | 1.10028776 |
46 | CASK | 1.07741831 |
47 | MINK1 | 1.03763066 |
48 | MAP2K4 | 1.01929176 |
49 | KSR2 | 1.01865753 |
50 | IRAK2 | 1.01752447 |
51 | FGFR3 | 0.99431657 |
52 | ACVR1B | 0.96721941 |
53 | BRAF | 0.96186409 |
54 | RET | 0.94679583 |
55 | CDK5 | 0.94139800 |
56 | CAMK2D | 0.91741692 |
57 | PTK2 | 0.90467096 |
58 | PDGFRA | 0.90173575 |
59 | TRPM7 | 0.89323352 |
60 | PRKCZ | 0.89240409 |
61 | PRKCE | 0.89101308 |
62 | TNIK | 0.87212890 |
63 | EPHA3 | 0.81163012 |
64 | OXSR1 | 0.81073662 |
65 | BRSK2 | 0.80498095 |
66 | CAMKK1 | 0.80472171 |
67 | CAMK2A | 0.77208136 |
68 | BCR | 0.76731785 |
69 | NTRK2 | 0.76337652 |
70 | FER | 0.76163822 |
71 | BMPR2 | 0.75971981 |
72 | PRKCG | 0.75224353 |
73 | CAMK2B | 0.73382979 |
74 | ERN1 | 0.73370609 |
75 | PAK6 | 0.72489411 |
76 | ADRBK1 | 0.72141194 |
77 | TRIM28 | 0.71285602 |
78 | MAPK13 | 0.70766700 |
79 | DYRK2 | 0.69776333 |
80 | PRKD2 | 0.69456978 |
81 | LIMK1 | 0.68982623 |
82 | SGK223 | 0.68677353 |
83 | SGK494 | 0.68677353 |
84 | WNK1 | 0.67186816 |
85 | BRSK1 | 0.62770750 |
86 | DYRK1A | 0.59249866 |
87 | ARAF | 0.58878370 |
88 | PTK2B | 0.58876259 |
89 | STK3 | 0.58818926 |
90 | CAMK1G | 0.58168701 |
91 | DYRK1B | 0.57006548 |
92 | MKNK2 | 0.56920835 |
93 | SGK2 | 0.56532113 |
94 | CSNK1G2 | 0.56434050 |
95 | TAOK1 | 0.56185833 |
96 | RPS6KA2 | 0.56180353 |
97 | NME1 | 0.56160037 |
98 | EPHA4 | 0.55619093 |
99 | NLK | 0.55594071 |
100 | CSNK1D | 0.52593883 |
101 | BMPR1B | 0.50092243 |
102 | EIF2AK3 | 0.49946731 |
103 | PRKAA1 | 0.48517945 |
104 | PRKG1 | 0.48499585 |
105 | STK39 | 0.47453693 |
106 | CAMK2G | 0.47435096 |
107 | PRKACA | 0.47248831 |
108 | SGK1 | 0.44967789 |
109 | ADRBK2 | 0.44744456 |
110 | SIK2 | 0.44681583 |
111 | PRKACB | 0.43939036 |
112 | CSNK1E | 0.43295384 |
113 | RPS6KB1 | 0.43202568 |
114 | PLK2 | 0.42372901 |
115 | PRKACG | 0.42345671 |
116 | ERBB3 | 0.41652463 |
117 | CSNK1A1 | 0.41555762 |
118 | STK11 | 0.40488096 |
119 | MARK2 | 0.40183114 |
120 | BRD4 | 0.39667329 |
121 | GSK3A | 0.39589098 |
122 | STK24 | 0.38560354 |
123 | PTK6 | 0.38366964 |
124 | RPS6KA3 | 0.37918197 |
125 | JAK2 | 0.36404842 |
126 | MAPK10 | 0.35768445 |
127 | PRKCA | 0.35274252 |
128 | KSR1 | 0.33752930 |
129 | PRKCI | 0.33388639 |
130 | MET | 0.32660310 |
131 | PRKCB | 0.31169116 |
132 | CDK14 | 0.30528401 |
133 | SGK3 | 0.29552911 |
134 | MAP2K1 | 0.29086944 |
135 | RPS6KA5 | 0.28400493 |
136 | DAPK1 | 0.28019881 |
137 | DAPK2 | 0.27609657 |
138 | IGF1R | 0.26386701 |
139 | PRKDC | 0.25582851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.64185892 |
2 | Protein export_Homo sapiens_hsa03060 | 4.22449308 |
3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.17641985 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 3.36337299 |
5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.53781695 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.45767316 |
7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.40958358 |
8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.40814839 |
9 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.29448289 |
10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28791879 |
11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26610222 |
12 | Cocaine addiction_Homo sapiens_hsa05030 | 2.20039406 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.07021559 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05574390 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90072902 |
16 | Taste transduction_Homo sapiens_hsa04742 | 1.75415390 |
17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73548542 |
18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71098309 |
19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68682022 |
20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67715448 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.66240686 |
22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58328520 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56252016 |
24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55866962 |
25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55552545 |
26 | Morphine addiction_Homo sapiens_hsa05032 | 1.52071284 |
27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.51893146 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51729848 |
29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35010474 |
30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34622276 |
31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.33023781 |
32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20964743 |
33 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.17814109 |
34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.14983178 |
35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13924098 |
36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12810258 |
37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12127308 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10398197 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09258788 |
40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09161795 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.07821684 |
42 | Renin secretion_Homo sapiens_hsa04924 | 1.04639422 |
43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03552245 |
44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99411369 |
45 | Long-term depression_Homo sapiens_hsa04730 | 0.98745830 |
46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96513881 |
47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95282792 |
48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93823909 |
49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92674368 |
50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89150566 |
51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86061156 |
52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83472693 |
53 | Prion diseases_Homo sapiens_hsa05020 | 0.82912962 |
54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82835940 |
55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82288494 |
56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81199233 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78974918 |
58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78683162 |
59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77684840 |
60 | Peroxisome_Homo sapiens_hsa04146 | 0.77670270 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77570650 |
62 | Salivary secretion_Homo sapiens_hsa04970 | 0.76534862 |
63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76024523 |
64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74551069 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72086398 |
66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70821582 |
67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70703496 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65220063 |
69 | Alcoholism_Homo sapiens_hsa05034 | 0.65210117 |
70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65177032 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64704586 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63505274 |
73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62242061 |
74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61849026 |
75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61319230 |
76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60926999 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58574490 |
78 | Gap junction_Homo sapiens_hsa04540 | 0.58537073 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55993378 |
80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55765597 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.55085215 |
82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54386827 |
83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54363816 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53976207 |
85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52996067 |
86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51959028 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51684821 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50222572 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50040640 |
90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49124219 |
91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48191626 |
92 | Melanogenesis_Homo sapiens_hsa04916 | 0.47343823 |
93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45888289 |
94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45666020 |
95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45317573 |
96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44899188 |
97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44613414 |
98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43730484 |
99 | Mineral absorption_Homo sapiens_hsa04978 | 0.42325483 |
100 | Phototransduction_Homo sapiens_hsa04744 | 0.41599263 |
101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41453347 |
102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40407741 |
103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40348309 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39139215 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39121088 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38121403 |
107 | Phagosome_Homo sapiens_hsa04145 | 0.37405391 |
108 | ABC transporters_Homo sapiens_hsa02010 | 0.37403888 |
109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36946364 |
110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36525132 |
111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35257509 |
112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34226556 |
113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32516036 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31871242 |
115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31218549 |
116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27739013 |
117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27021513 |
118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26558227 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26307755 |
120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26114016 |
121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25708682 |
122 | Glioma_Homo sapiens_hsa05214 | 0.25414943 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24566697 |
124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24495330 |
125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24217316 |
126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23843337 |
127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22981926 |
128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22894636 |